StemEdit hiPSC B2M/CIITA DKO RPC-LLF-34-F3
Reprocell

StemEdit hiPSC B2M/CIITA DKO RPC-LLF-34-F3

Cat # Size
RCRP052 1 vial (1 million cells)
Have questions? Message Us

Overview

Ready-to-use Research-Grade HLA Class I and II double knockout iPSCs made using REPROCELL’s RNA Reprogramming Technology.
These cells feature all the advantages of our RNA reprogramming technology, including no retention of reprogramming factors and easy culture in NutriStem hPSC XF Medium (Cat. No. 01-0005) on iMatrix-511 (Cat. No. NP892-011). They have been engineered using OpenCRISPR-1 to contain B2M (HLA Class I) and  CIITA (HLA Class II)  double knockout mutations, which are carefully characterized and offer significant time savings compared to creating your own reprogrammed and edited cell lines.

NOTE:  

These iPSC cell lines are developed and supplied for Research Use Only (RUO). They are not intended for clinical or therapeutic applications. However, this clone has a clinical-grade counterpart available that is suitable for clinical gene editing and downstream clinical development. If you require material for translational or clinical programs, please see Clinical Stem Cell Services or Contact Us for more information.

See also our complete collections of Research Use Only StemRNA™ Induced Pluripotent Stem Cells (iPSCs) and StemEdit Gene-Edited iPSC Lines.


Table: Characteristics of StemEdit hiPSC B2M/CIITA DKO RPC-LLF-34-F3 Cells
Cat. No.: RCRP052
Mutation: B2M/CIITA double knockout
Mutation validation:

DNA Sequencing, B2M expression (flow)

Parent Clone ID:

StemRNA Clinical iPSC Clone LLF-34-F3

Donor Blood Type:

O positive

Donor Race: Caucasian
Donor Sex: Female
Donor Age: 22
Reprogramming Technology: StemRNA Clinical Reprogramming Technology
Tissue Source: Skin (Fibroblasts)
Karyotype: Normal (46 XX)
Microbiology: Negative for bacteria, viruses, and mycoplasma

Specifications

Product Name: StemEdit hiPSC B2M/CIITA DKO RPC-LLF-34-F3

Product Description: Human iPSCs established from fibroblasts, reprogrammed with REPROCELL's Clinical StemRNA Reprogramming technology, with double knockout in the B2M (HLA Class I) and CIITA (HLA Class II) genes.

Parental Strain ID: StemRNA Clinical iPSC Clone LLF-34-F3

Tissue Source: Skin (fibroblasts)

Catalog Number: RCRP052

Donor Information

  • Race: Caucasian
  • Sex: Female
  • Age: 22 years old

Precryopreservation Culture Conditions

  • Culture Medium: NutriStem hPSC XF Culture Medium (Cat No 01-0005)
  • Culture Matrix: iMatrix-511 (Cat. No. NP892-011)
  • Cryopreservation Medium: NutriFreez™ D10 Freezing Medium (Cat. No. 01-0020-50)

Size: 1 vial, 1 × 106 cells per vial

Storage: Store in liquid nitrogen vapor phase.

Quality Control

  • Pluripotency by ICC, flow cytometry: Pass
  • Knockout verification by NGS, flow cytometry: Pass
  • Viability: ≥ 70 %
  • Bacteria: Negative
  • Mycoplasma: Negative
  • Virus (HIV1&2, HBV, HCV): Negative
  • Karyotype: 46, XX

Sterility: Sterile

Notice To Purchaser: This product is intended for Research Use Only. Commercial Use may require additional agreements. Please contact info-us@reprocell.com for more information. This Product is not intended for Clinical or Diagnostic Use.